Clinical Trial Update: Effects of Obex in Overweight and Obese Patients [Phase 2, Phase 3]

View source ↗

Summary

Obex was evaluated in overweight and obese patients in Phase 2 and Phase 3 trials; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Obex

Snippet

Sponsor: Catalysis SL | Conditions: Overweight, Obesity | Phase 2, Phase 3 | Status: COMPLETED